Septerna (SEPN) awards CMO 275,000 options at $37.37
Septerna (SEPN) disclosed that its CMO, Rajiv Patni, received 275,000 stock options on September 8, 2026, with an exercise price of $37.37 per share. The options expire on September 7, 2036, with 25% vesting on August 24, 2027, and the remainder in monthly installments over three years, contingent on his continued service.
How this was made
The 30-second read
Why it matters
The grant adds 275,000 options at $37.37 exercise price, vesting over 36 months, with no immediate cash flow impact.
Market read
Limited relevance; primarily of interest to existing shareholders and insiders.
What to watch
Potential future dilution if options are exercised; monitor subsequent insider activity.
Background
Form 4 filing reporting an equity compensation grant to a senior executive.
Ticker impact
Septerna disclosed a grant of 275,000 stock options to its CMO Rajiv Patni, vesting over 36 months.
minimal effect, likely negligible on share price
The grant size is modest relative to market cap and no cash transaction occurred.
Market effects
None; the grant is specific to Septerna and does not affect the broader biotech sector.
None; limited to the company's shareholders.
None
Counterpoint
Even small insider grants can signal confidence; some investors may view it positively.
Key entities
- CompanySepterna, Inc.
Biotech company issuing the options.
- ExecutiveRajiv Patni
Chief Medical Officer receiving the option grant.
